The 61 rating InvestorsObserver gives to Meridian Bioscience, Inc. (VIVO) stock puts it near the top of the Diagnostics & Research industry. In addition to scoring higher than 88 percent of stocks in the Diagnostics & Research industry, VIVO’s 61 overall rating means the stock scores better than 61 percent of all stocks.
VIVO has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on VIVO!